1,020
Views
2
CrossRef citations to date
0
Altmetric
Bedside to Bench Report

Efficacy generated by afatinib in a lung adenocarcinoma patient harboring HER2 S310Y mutation

, , , , , , & show all
Pages 450-453 | Received 07 Dec 2017, Accepted 03 Mar 2018, Published online: 12 Apr 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.